Trump Bought Up to $5M in Axon Stock Before ICE's $220M Taser Deal
Trump held up to $5M in Axon shares before ICE pursued a $220M Taser contract, raising conflict-of-interest questions.
Here's the kind of trade setup that would get a retail investor banned from the industry: buy up to $5 million in a company's stock, then watch a federal agency you oversee pursue a $220 million contract with that same company. That's the situation surrounding Donald Trump and Axon Enterprise, the maker of Tasers and law enforcement tech.
Axon has been aggressively working the halls of Congress, ramping up its lobbying on federal law enforcement technology right as ICE — an agency under the executive branch Trump leads — began chasing a potential $220 million Taser deal with the firm. The timing alone is the kind of thing that makes conflict-of-interest watchdogs reach for their red pens.
Read more US-Iran Nuclear Talks Resume Tuesday in Qatar After Tense Weekend →
For traders, the real story here is Axon's positioning. The company isn't just selling stun guns anymore — it's deep into federal government contracts, and that lobbying push signals serious institutional intent to lock in long-term revenue from Washington. A $220 million ICE deal would be a meaningful contract win and a signal that federal law enforcement tech is a growth lane worth watching.
The political optics are rough, and scrutiny is only going to build the longer this contract stays in play. Whether or not the deal closes, the spotlight on Axon's government sales strategy — and the questions around executive branch stock holdings — puts this name squarely on the radar. Controversy has a funny way of driving volume.
Continue reading at US Top News and Analysis.
